TGFβ3 inhibitors constitute a distinct chemical class of compounds designed to intricately regulate the signaling pathways associated with Transforming Growth Factor Beta 3 (TGFβ3). As a member of the TGF-β superfamily of cytokines, TGFβ3 plays a critical role in numerous cellular processes, most notably in embryonic development, wound healing, and tissue repair. The inhibitors within this class are precisely engineered to interact with specific components of the TGFβ3 signaling cascade, including its receptors or downstream effectors. By engaging in these interactions, TGFβ3 inhibitors proficiently disrupt the binding and activation of TGFβ3 to its receptors, thereby impeding the subsequent intracellular signaling events that would otherwise ensue. The primary function of TGFβ3 inhibitors revolves around modulating TGFβ3 signaling, which, in turn, offers researchers a powerful and versatile tool to meticulously explore the intricacies of TGFβ3-mediated biological responses. These inhibitors are instrumental in deciphering the molecular mechanisms underlying TGFβ3's regulatory role in various physiological and pathological contexts. By selectively inhibiting TGFβ3, researchers gain a comprehensive understanding of its contribution to cellular processes, ranging from embryogenesis to tissue remodeling. Furthermore, studying TGFβ3 inhibitors helps elucidate the complex interplay between TGFβ3 and other essential cellular pathways, shedding light on the multifaceted regulatory functions of this cytokine within the cellular milieu.
The significance of TGFβ3 inhibitors lies in their ability to pave the way for innovative research endeavors. Their utility lies in the elucidation of fundamental biological processes, thereby expanding our knowledge of TGFβ3's involvement in diverse cellular contexts. As researchers continue to delve into the intricacies of TGFβ3 signaling, TGFβ3 inhibitors remain pivotal in advancing our understanding of this crucial cytokine and its profound influence on cellular responses.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $209.00 $352.00 | 3 | |
LY2157299 is a small molecule inhibitor of the TGF-β receptor I kinase (ALK5). | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
SB431542 is a selective small molecule inhibitor of the TGF-β type I receptor (ALK5). It has been widely used in research to block TGF-β signaling and understand its role in various cellular processes. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $100.00 $408.00 | 6 | |
While it primarily inhibits TGF-β1, Pirfenidone has also been reported to have some inhibitory effects on TGF-β | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $86.00 | 3 | |
TGF-β RI Kinase Inhibitor V is another small molecule inhibitor targeting the TGF-β receptor I kinase (ALK5). It has been studied for its potential anti-fibrotic and anti-cancer properties. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
GW788388 is a selective small molecule inhibitor of the TGF-β type I receptor kinase (ALK5) and has been explored in some studies for fibrotic diseases. | ||||||
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $87.00 $270.00 | 9 | |
LY2109761 is a small molecule inhibitor of both TGF-β receptor I (ALK5) and the activin receptor-like kinase 4 (ALK4). It has been investigated for its potential anti-tumor effects. | ||||||
LY-333,531 Hydrochloride | 169939-93-9 | sc-364215 sc-364215A | 1 mg 5 mg | $92.00 $281.00 | 6 | |
While it was initially developed as a protein kinase C (PKC) inhibitor, LY333531 has also been found to inhibit TGF-β2-induced effects in certain contexts. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
Primarily known as a tyrosine kinase inhibitor targeting Bcr-Abl in leukemia, Nilotinib has also been reported to have inhibitory effects on TGF-β2. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $30.00 $101.00 $277.00 $959.00 | 2 | |
Tranilast is an anti-allergy drug that has been found to have inhibitory effects on TGF-β2-induced fibrosis. | ||||||